Health-Related Quality of Life across Recent Pediatric Obesity Classification Recommendations

William R Black1,2, Kelsey B Borner3, Marshall T Beauchamp4

  • 1Center for Children's Healthy Lifestyles & Nutrition, Kansas City, MO 64108, USA.

Insights

New obesity metric, BMI95pct, better captures health differences in children. Class III obesity shows lower quality of life than Class I and II, highlighting the need for refined categorization in severe obesity research.

Area of Science:

  • Pediatric Endocrinology
  • Obesity Medicine
  • Health Outcomes Research

Background:

  • Standard growth curves may inaccurately represent extreme body mass index (BMI) values, limiting clinical utility.
  • Percentage of BMI above the 95th percentile (BMI95pct) is a proposed metric for better assessing severe obesity.
  • Limited research exists on BMI95pct's ability to differentiate psychosocial outcomes compared to traditional methods.

Purpose of the Study:

  • To evaluate child obesity severity using BMI95pct.
  • To examine group differences in Health-Related Quality of Life (HRQoL) based on BMI95pct classifications.
  • To determine if BMI95pct refines understanding of clinical psychosocial constructs in pediatric obesity.

Main Methods:

  • Cross-sectional study involving 465 children with obesity.
  • Classification into obesity classes based on BMI95pct: Class I (≥100% to <120%), Class II (≥120% to <140%), Class III (≥140%).
  • Assessment of HRQoL using the validated Sizing Me Up self-report measure.

Main Results:

  • Children with Class III obesity reported significantly lower HRQoL than those in Class I and Class II.
  • No significant HRQoL differences were found between Class I and Class II obesity.
  • Combining severe obesity classes (II and III) in prior research may obscure critical HRQoL variations.

Conclusions:

  • BMI95pct provides a more nuanced assessment of obesity severity and its impact on pediatric HRQoL.
  • Distinguishing between Class II and Class III obesity is crucial for understanding clinical outcomes.
  • Future research on severe pediatric obesity should utilize refined classifications to capture functional and clinical differences.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
44
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
872
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
65
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
13.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
56
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
250